17 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

MRK

Merck
AR$21,400.00-4.9%-1.4%AR$255.5bAR$27,882.60PE20.8xE16.0%3.2%

GILD

Gilead Sciences
AR$24,625.00-2.6%20.6%AR$115.1bAR$26,347.81PE913.7xE40.6%3.3%

BMYD

New
Bristol-Myers Squibb
€20.60n/an/a€117.9b€21.47PS2.5xE48.8%4.1%

BIIB

Biogen
AR$13,000.00-4.9%-35.1%AR$22.8bAR$20,537.58PE14.2xE12.4%n/a

BMY

Bristol-Myers Squibb
AR$20,275.00-5.4%16.4%AR$117.9bAR$21,680.52PS2.4xE48.7%4.2%

MRKD

Merck
US$20.60-6.4%12.0%US$255.5bUS$26.84PE20.8xE16.0%3.2%

BIIBD

Biogen
US$12.700%n/aUS$22.8bUS$20.06PE14.2xE12.4%n/a

NVSD

Novartis
US$25.00-12.0%n/aUS$177.5bUS$28.68PE17.1xE7.0%3.6%

GSKD

GSK
US$8.70-6.3%n/aUS$54.7bUS$11.79PE21.8xE23.2%4.3%

NVS

Novartis
AR$26,550.00-5.3%6.6%AR$175.8bAR$30,794.26PE16.9xE7.0%3.6%

GSK

GSK
AR$9,200.00-3.7%-1.3%AR$54.7bAR$12,469.43PE21.8xE23.2%4.3%

GILDD

Gilead Sciences
US$23.20-3.3%-3.3%US$115.1bUS$24.82PE913.7xE40.6%3.3%

ROSE

Instituto Rosenbusch
AR$118.75-1.0%74.6%AR$5.1bn/aPE5xn/an/a

AMGND

New
Amgen
US$9.201.7%4.5%US$148.2bUS$10.95PE34.7xE18.5%3.3%

TMOD

Thermo Fisher Scientific
US$28.500%n/aUS$205.0bUS$34.77PE33.4xE11.5%0.3%

AMGN

New
Amgen
AR$9,830.00-4.3%4.5%AR$148.2bAR$11,697.50PE34.7xE18.5%3.3%

TMO

Thermo Fisher Scientific
AR$26,100.00-2.0%11.8%AR$205.0bAR$31,928.49PE33.3xE11.5%0.3%
Page 1 of 1